Synthesis, molecular docking and antibacterial evaluation of various quinoline schiff bases: labeling and biodistribution of 99mTc-2-(p-hydroxybenzylidene)-1-(quinolin-4-yl)hydrazine

被引:6
作者
Al-wabli, Reem I. [1 ]
Khedr, Mohammed A. [2 ,3 ]
Kadi, Adnan A. [1 ]
Motaleb, Mohammed A. [4 ]
Al-rashood, Khalid A. [1 ]
Zaghary, Wafaa A. [1 ,3 ]
机构
[1] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia
[2] King Faisal Univ, Dept Pharmaceut Sci, Coll Clin Pharm, Al Hasa, Saudi Arabia
[3] Helwan Univ, Dept Pharmaceut Chem, Coll Pharm, Cairo 11795, Egypt
[4] Atom Energy Author, Labeled Compound Dept, Hot Labs Ctr, Cairo 13759, Egypt
关键词
Quinoline; Benzylidene; Molecular docking; Antimicrobial activity; Technetium-99m; BIOLOGICAL CHARACTERISTICS; SCINTIGRAPHIC DETECTION; ANTIMICROBIAL PEPTIDES; BACTERIAL-INFECTION; DETECTING SITES; INFLAMMATION; AGENT; DIAGNOSIS; COMPLEX;
D O I
10.1007/s00044-014-0977-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 2-(substituted benzylidene)-1-(quinoline-4-yl)hydrazine was designed, synthesized, and evaluated for their antimicrobial activity. A molecular docking study was performed against bacterial topoisomerase II (PDB code: 2XCT) using MOE 2012.10 and Leadit 2.1.2 softwares. Compound 4a with the highest antibacterial activity was labeled with one of the most important radioactive isotopes (technetium-99m). (99m) Tc-4a complex showed high labeling yield, stability, and uptake in the inflamed tissue (T/NT = 6.11 +/- A 0.5) compared to the commercially available Tc-99m-ciprofloxacin (T/NT = 3.6 +/- A 0.4).
引用
收藏
页码:4011 / 4020
页数:10
相关论文
共 34 条
[1]   Labeling and biodistribution of 99mTc-7-bromo-1,4-dihydro-4-oxo-quinolin-3-carboxylic acid complex [J].
Al-wabli, Reem I. ;
Motaleb, M. A. ;
Kadi, Adnan A. ;
Al-rashood, Khalid A. ;
Zaghary, Wafaa A. .
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2011, 290 (02) :507-513
[2]   Detecting inflammation with 131I-labeled ornidazole [J].
Asikoglu, M ;
Yurt, F ;
Cagliyan, O ;
Unak, P ;
Ozkilic, H .
APPLIED RADIATION AND ISOTOPES, 2000, 53 (03) :411-413
[3]  
Britton KE, 1997, EUR J NUCL MED, V24, P553
[4]   Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton) [J].
Britton, KE ;
Wareham, DW ;
Das, SS ;
Solanki, KK ;
Amaral, H ;
Bhatnagar, A ;
Katamihardja, AHS ;
Malamitsi, J ;
Moustafa, HM ;
Soroa, VE ;
Sundram, FX ;
Padhy, AK .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (11) :817-823
[5]  
CAGLAR M, 1995, CLIN NUCL MED, V20, P712
[6]  
Dams ETM, 2000, J NUCL MED, V41, P622
[7]  
Das SS, 2003, WORLD J NUCL MED, V2, P173
[8]   Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines [J].
De, DYD ;
Krogstad, FM ;
Byers, LD ;
Krogstad, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :4918-4926
[9]   The role of nuclear medicine in inflammatory bowel disease.: A review with experiences of aspecific bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies [J].
Györke, T ;
Duffek, L ;
Bártfai, K ;
Makó, E ;
Karlinger, K ;
Mester, A ;
Tarján, Z .
EUROPEAN JOURNAL OF RADIOLOGY, 2000, 35 (03) :183-192
[10]   Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure [J].
Jacobs, MR ;
Bajaksouzian, S ;
Palavecino-Fasola, EL ;
Holoszyc, HM ;
Appelbaum, PC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) :179-183